Production of M2000 (β-d-mannuronic acid) and its therapeutic effect on experimental nephritis

Environmental Toxicology and Pharmacology

Volumn 24, Issue 1, 2007, Pages 60-66

  Mirshafiey, A ^a   Rehm, B ^b   Abhari, R Safari ^a   Borzooy, Z ^a   Sotoude, M ^a   Razavi, A ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASSEY UNIVERSITY   (New Zealand)

Author keywords

Anti inflammatory; Glomerulonephritis; M2000; NSAIDs; Proteinuria

Indexed keywords

CHOLESTEROL; CREATININE; DEXAMETHASONE; DICLOFENAC; GELATINASE A; MANNURONIC ACID; PIROXICAM; PROTEIN; TRIACYLGLYCEROL; UREA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROSARCOMA; GLOMERULONEPHRITIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PSEUDOMONAS FLUORESCENS; RAT; TRIACYLGLYCEROL BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; ZYMOGRAPHY;

ANIMALIA; BOVINAE; PSEUDOMONAS FLUORESCENS; RATTUS;

EID: 34247107674     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etap.2007.02.002     Document Type: Article

References (37)

1. Basivireddy J., Jacob M., Pulimood A.B., and Balasubramanian K.A. Indomethacin-induced renal damage: role of oxygen free radicals. Biochem. Pharmacol. 67 (2004) 587-599
2. Blumenkrantz N., and Asboe-Hansen G. New method for quantitative determination of uronic acids. Anal. Biochem. 54 (1973) 484-489
3. Bousnes R.W., and Taussky A.A. The calorimetric determination of creatinine by the Jaffe reaction. J. Biol. Chem. 158 (1945) 581-591
4. Bucke C. Cell immobilization in calcium alginate. Meth. Enzymol. 135 (1987) 175-188
5. Camp T.M., Smiley L.M., Hayden M.R., and Tyagi S.C. Mechanism of matrix accumulation and glomerulosclerosis in spontaneously hypertensive rats. J. Hypertens. 21 (2003) 1719-1727
6. Cattran D.C. Outcomes research in glomerulonephritis. Semin. Nephrol. 23 (2003) 340-354
7. Chadban S. Glomerulonephritis recurrence in the renal graft. J. Am. Soc. Nephrol. 12 (2001) 394-402
8. Evans R.T. Manual and automated methods for measuring urea based on a modification of its reaction with diacetyl monoxime and thiosemicarbazide. J. Clin. Pathol. 2 (1968) 527-532
9. Filisetti-Cozzi T.M., and Carpita N.C. Measurement of uronic acids without interference from neutral sugars. Anal. Biochem. 197 (1991) 157-162
10. S injury. Am. J. Kidney Dis. 42 (2003) A41-A51
11. Galambos J.T. The reaction of carbazole with carbohydrates. I. Effect of borate and sulfamate on the carbazole color of sugars. Anal. Biochem. 19 (1967) 119-132
12. Harendza S., Schneider A., Helmchen U., and Stahl R.A. Extracellular matrix deposition and cell proliferation in a model of chronic glomerulonephritis in the rat. Nephrol. Dial. Transplant. 12 (1999) 2873-2879
13. Heussen C., and Dowdle E.B. Electrophoretic analysis of plasminogen activator in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal. Biochem. 102 (1980) 196-202
14. Hogendoorn P.C.W., Bruijn J.A., Gelok E.W.A., Van Den Broek L.J.C.M., and Fleuren G.J. Development of progressive glomerulosclerosis in experimental chronic serum sickness. Nephrol. Dial. Transplant. 5 (1990) 100-109
15. Hricik D.E., Chung-park M., and Sedor J.R. Glomerulonephritis. N. Engl. J. Med. 339 (1998) 888-899
16. Kaiser A. Diclofenac caused renal insufficiency. A case illustrating the necessity of pharmaceutical intervention and care. Med. Monatsschr Pharm. 26 (2003) 384-388
17. Lenz O., Elliot S.J., and Stetler-Stevenson W.G. Matrix metalloproteinases in renal development and disease. J. Am. Soc. Nephrol. 11 (2000) 574-581
18. Lovett D.H., Johnson R.J., Marti H.P., Martin J., Davies M., and Couser W.G. Structural characterization of the mesangial cell type IV collagenase and enhanced expression in a model of immune complex-mediated glomerulonephritis. Am. J. Pathol. 141 (1992) 85-98
19. Marti H.P. The role of matrix metalloproteinases in the activation of mesangial cells. Transpl. Immunol. 9 (2002) 97-100
20. Mirshafiey A., Rehm B.H., Sahmani A.A., Naji A., and Razavi A. M-2000, as a new anti-inflammatory molecule in treatment of experimental nephrosis. Immunopharmacol. Immunotoxicol. 26 (2004) 611-619
21. Mirshafiey A., Matsuo H., Nakane S., Rehm B.H., Koh C.S., and Miyoshi S. Novel immunosuppressive therapy by M2000 in experimental multiple sclerosis. Immunopharmacol. Immunotoxicol. 27 (2005) 255-265
22. Mirshafiey A., Cuzzocrea S., Rehm B., Mazzon E., Saadat F., and Sotoude M. Treatment of experimental arthritis with M2000, a novel designed non-steroidal anti-inflammatory drug. Scand. J. Immunol. 61 (2005) 435-441
23. O'Callaghan C.A. Renal manifestations of systemic autoimmune disease: diagnosis and therapy. Best Pract. Res. Clin. Rheumatol. 18 (2004) 411-427
24. Perazella M.A. Drug- induced renal failure: update on new medications and unique mechanisms of nephrotoxicity. Am. J. Med. Sci. 325 (2003) 349-362
25. Quigg R.J. Complement and autoimmune glomerular diseases. Curr. Dir Autoimmun 7 (2004) 165-180
26. Rehm B.H.A. Alginate lyase from pseudomonas aeruginosa CF1/M1 prefers the hexameric oligomannuronate as substrate. FEMS Microbiol. Lett. 165 (1998) 175-180
27. Rehm B.H., and Valla S. Bacterial alginates: biosynthesis and applications. Appl. Microbiol. Biotechnol. 48 (1997) 281-288
28. Reinhold S.W., Fischereder M., Riegger G.A., and Kramer B.K. Acute renal failure after administration of a single dose of a highly selective COX-2 inhibitor. Clin. Nephrol. 60 (2003) 295-296
29. Rougier J.P., and Ronco P. Pathogenesis of immune glomerulonephritis. Rev. Prat. 53 (2003) 1998-2004
30. Sanders J.S., van Goor H., Hanemaaijer R., Kallenberg C.G., and Stegeman C.A. Renal expression of matrix metalloproteinases in human ANCA-associated glomerulonephritis. Nephrol. Dial. Transplant. 19 (2004) 1412-1419
31. Skjak-Braek G., Grasdalen H., and Larsen B. Monomer sequence and acetylation pattern in some bacterial alginates. Carbohydrate Res. 15 (1986) 239-250
32. Stollbergen C., and Finsterer J. Side effects of conventional nonsteroidal anti-inflammatory drugs and celecoxib: more similarities than differences. South Med. J. 97 (2004) 209-219
33. Tarzi R.M., and Cook H.T. Role of Fcgamma receptors in glomerulonephritis. Nephron Exp. Nephrol. 95 (2003) e7-e12
34. Vilim V. Colorimetric estimation of uronic acids using 2-hydroxydiphenyl as a reagent. Biomed. Biochim. Acta 44 (1985) 1717-1720
35. Vinen C.S., and Oliveira D.B.G. Acute glomerulonephritis. Postgrad. Med. J. 79 (2003) 206-213
36. Yamamoto T., Kihara I., Morita T., and Oite T. Bovine serum albumin (BSA) nephritis in rats. I. Experimental model. Acta Pathol. Jpn. 28 (1978) 859-860
37. Zhang Z.G., Liu X.G., Chen G.P., Zhang X.R., and Guo M.Y. Significance of MMP-2 and TIMP-2 mRNA expressions on glomerular cells in the development of glomerulosclerosis. Med. Sci. J. 19 (2004) 84-88